Defining 'relative' androgen deficiency in aging men: How should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?

Climacteric

Volumn 5, Issue 1, 2002, Pages 15-25

  Haren, M T ^a   Morley, J E ^b   Chapman, I M ^a   O'Loughlin, P D ^c   Wittert, G A ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Aging; Body composition; Cognitive function; Libido; Men; Muscle strength; Testosterone

Indexed keywords

ANDROGEN; TESTOSTERONE;

ADULT; AGED; AGING; BODY FAT; CLINICAL FEATURE; COGNITIVE DEFECT; DEPRESSION; DRUG SAFETY; EMOTIONAL STABILITY; ERECTILE DYSFUNCTION; FATIGUE; HEALTH STATUS; HORMONE DEFICIENCY; HORMONE DETERMINATION; HUMAN; LIBIDO; MALE; MUSCLE MASS; MUSCLE STRENGTH; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL;

EID: 0036226447     PISSN: 13697137     EISSN: None     Source Type: Journal    
DOI: 10.1080/cmt.5.1.15.25     Document Type: Review

References (94)

1. Age related changes in the pituitary-testicular axis in normal men; lower serum testosterone results from decreased bioactive LH drive
2. Impotence and aging: Clinical and hormonal factors
3. Age-related changes in male gonadal function. Implications for therapy
4. Decreased bioavailable testosterone in aging normal and impotent men
5. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community dwelling men
6. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: Response to clomiphene citrate
7. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men
8. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men
9. Baltimore longitudinal study of aging
10. Androgens and aging
11. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial
12. The free hormone hypothesis: A physiologically based mathematical model
13. Bioavailability of albumin-bound testosterone
14. Effects of testosterone on body weight and adipose tissue: Role of aromatisation
15. Solubilization and partial characterization of the sex hormone-binding globulin receptor from human prostate
16. The control and interaction of sex hormone-binding globulin with its receptor by steroid hormones
17. Biologically active steroids activate receptor-bound human sex hormone-binding globulin to cause LNCaP cells to accumulate adenosine 3′,5′-monophosphate
18. Testosterone metabolism in human bone
19. The metabolism of 7-α-3H-testosterone by rat mandibular bone
20. Sex hormone binding globulin: Origin, function and clinical significance
21. The apparent free testosterone concentration, an index of androgenicity
22. A critical evaluation of simple methods for the estimation of free testosterone in serum
23. Plasma androgens and sex hormone-binding globulin in the evaluation of hirsute females
24. The free androgen index is not valid for adult males
25. The measurement of sex steroid binding globulin by differential ammonium sulphate precipitation
26. The calculation of bioavailable testosterone. Andrology in the 21st Century
27. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging study
28. Androgens, estrogens, and sex hormone-binding globulin in middle-aged men
29. The relation of smoking, age, relative weight, and dietery intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men
30. Age-related decline of plasma bioavailable testosterone in adult men
31. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulphate, and the ratio of insulin-like growth factor 1 to growth hormone
32. The influence of aging on plasma sex hormones in men: The Telecom study
33. Changes in the pituitary-testicular system with age
34. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: Cross-sectional data from a healthy male cohort
35. Variation with age in the levels of sex-steroid-binding plasma protein as determined by radioimmunoassay
36. Testosterone and the aging male
37. Validation of a screening questionnnaire for androgen deficiency in aging males
38. Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men
39. Effect of testosterone administration on sexual behaviour and mood in men with erectile dysfunction
40. The relationship between pituitary-gonadal function and sexual behaviour in healthy aging men
41. The regulation of male sexual behaviour by the sex hormones
42. Age-associated testosterone decline in men: Clinical issues for psychiatry
43. A long-term prospective study of the physiologic and behavioural effects of hormone replacement in untreated hypogonadal men
44. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo study
45. Plasma testosterone levels, depression, sexuality, and age
46. Testosterone influences spatial cognition in older men
47. Endogenous sex hormones and cognitive function in older men
48. A curvilinear relationship between testosterone and spatial cognition in humans: Possible influence of hand preference
49. Pathogenesis of the decreased androgen levels in obese men
50. Plasma free and non-sex-hormone binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity
51. Obesity and metabolic complications: Contribution of dehydroepiandrosterone and other steroid hormones
52. Androgens and abdominal obesity
53. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese older men
54. Lower endogenous androgens predict central adiposity in men
55. Long-term testosterone administration increases visceral fat in female to male transsexuals
56. Difficulties in measuring the effect of testosterone replacement therapy on muscle function in older men
57. Predictors of skeletal muscle mass in elderly men and women
58. Sex hormones and bone mineral density in elderly men
59. Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis
60. Bone density, bone turnover, and hormone levels in men over age 75
61. Aromatisation of androgens is important for skeletal maintenance of aged male rats
62. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men
63. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men
64. Relationship of high density lipoprotein cholesterol with total and free testosterone and sex hormone-binding globulin
65. Relationships of serum lipoproteins and apoproteins to sex hormones and to the binding capacity of sex hormone binding globulin in healthy Finnish men
66. Relationships of plasma lipoprotein concentrations to unbound, albumin-bound and sex hormone-binding globulin bound fractions of gonadal steroids in men
67. Endogenous sex hormones and cardiovascular disease in men: A prospective population based study
68. Associations between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom study
69. Mortality and morbidity in transsexual subjects treated with cross-sex hormones
70. Effect of testosterone treatment on bone mineral density in men over 65 years of age
71. Outcomes of long-term testosterone replacement in older hypogonadal males: A retrospective analysis
72. Transdermal testosterone gel improves sexual function, mood, muscle strength and body composition parameters in hypogonadal men
73. Long-term efficacy and safety of a permeation enhanced testosterone transdermal system in hypogonadal men
74. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study
75. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis
76. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age
77. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism
78. A replacement dose of testosterone increases muscle mass and size in hypogonadal men
79. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - A Clinical Research Centre study
80. Testosterone replacement therapy improves mood in hypogonadal men - A Clinical Research Centre study
81. Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls
82. Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men
83. The effects of chronic high dose androgen or oestrogen treatment on the human prostate
84. The long-term beneficial effects of low dose testosterone in the aging male
85. Testosterone therapy for low sexual interest and erectile dysfunction in men: A controlled study
86. The effects of exogenous testosterone on sexuality and mood of normal men
87. Testosterone supplementation for hypogonadal impotence: Assessment of biochemical measures and therapy outcomes
88. Effects of testosterone supplementation in the aging male
89. Testosterone treatment improves body composition and muscle strength in hypogonadal men
90. Androgen-behaviour correlations in hypogonadal men and eugonadal men. Cognitive abilities
91. Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men
92. Androgen treatment of abdominally obese men
93. Prospective study of sex hormone levels and risk of prostate cancer
94. Endogenous sex-hormones and prostate cancer: A quantitative review of prospective studies